FREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPINGFREE SHIPPING ON ORDERS $150+THIRD-PARTY LAB TESTEDCOA ON EVERY BATCHDISCREET SHIPPING

Research Library ยท Compound Guide

CJC-1295 (No DAC / Modified GRF 1-29): Research Overview & Molecular Profile

CJC-1295 without DAC - also referred to in the literature as Modified GRF (1-29) - is a synthetic peptide derivative of growth-hormone-releasing hormone (GHRH). It represents a modified analog of the first 29 amino acids of GHRH. The "No DAC" designation distinguishes it from the DAC (Drug Affinity Complex) conjugated version: unlike CJC-1295 DAC, the No-DAC form does not carry the DAC moiety and, in research characterization, exhibits a shorter circulating half-life. It is supplied as a lyophilized research powder for laboratory study. At AurexBioLabs, CJC-1295 (No DAC) is supplied strictly as a research compound with third-party testing and a Certificate of Analysis on every batch.

For Research Use Only. Not for human or veterinary use. Not a drug, food, or cosmetic. This page is educational reference material for qualified researchers and contains no medical advice, dosing, or health claims.

CJC-1295 (No DAC) Molecular Profile

CJC-1295 (No DAC) molecular profile
Compound typeSynthetic GHRH analog / peptide (Modified GRF 1-29)
Molecular formulaC152H252N44O42
Molecular weight~3367.9 g/mol
CAS number446036-97-1
Also known asModified GRF (1-29), CJC-1295 DAC-free, GHRH (1-29) analog
Physical formLyophilized white powder

Research Context

In preclinical literature, CJC-1295 (No DAC) is described as a growth-hormone-releasing hormone analog studied in laboratory models of the GHRH signaling pathway. A frequent focus of published characterization is the structural and pharmacokinetic difference between the No-DAC and DAC-conjugated forms - specifically the effect of the DAC moiety on half-life in research models. CJC-1295 has not been approved by the FDA for any human or veterinary use. Referenced findings are limited to laboratory research; consult primary sources for detail.

Handling & Laboratory Considerations

Storage

Lyophilized material stored frozen, protected from light.

Reconstitution (research context)

Bacteriostatic or sterile water per protocol; refrigerate reconstituted solution.

Stability

Avoid repeated freeze-thaw; protect from heat and light.

Quality & Verification at AurexBioLabs

Every batch of CJC-1295 (No DAC) is third-party HPLC and mass-spec verified, with a Certificate of Analysis. Check your lot number at our verification page.

Frequently Asked Questions

The DAC (Drug Affinity Complex) version carries an added moiety associated with a longer circulating half-life in research models; the No DAC form (Modified GRF 1-29) does not, and shows a shorter half-life in characterization studies.

Approximately 3367.9 g/mol.

446036-97-1.

Yes - the two names refer to the same DAC-free GHRH analog.

Yes - HPLC and mass-spec verified with a COA per batch.

Next Steps

Verification & catalog

For Research Use Only. Not for human or veterinary use. Not a drug, food, or cosmetic. This page is educational reference material for qualified researchers and contains no medical advice, dosing, or health claims.

CJC-1295 (No DAC) is sold for laboratory research use only. Not for human or veterinary use, diagnostic, or therapeutic purposes.